Inhibition of tetraphenylphosphonium-induced NMR-visible lipid accumulation in human breast cells by chlorpromazine

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1633, Issue 3, 2003, Pages 149-160

  Sathasivam, Nalayini ^a   Brammah, Susan ^b   Wright, Lesley C ^a   Delikatny, Edward J ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Department of Microbiology and Infectious Diseases   (Australia)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chlorpromazine; Lipid accumulation; Lipid metabolism; NMR; NMR visible lipid; Tetraphenylphosphonium chloride

Indexed keywords

CATION; CHLORIDE; CHLORPROMAZINE; FAT DROPLET; LIPID; TETRAPHENYLPHOSPHONIUM; TETRAPHENYLPHOSPHONIUM CHLORIDE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTICLE; ATTENUATION; BREAST CELL; CELL DAMAGE; CELL INCLUSION; CELL METABOLISM; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; ELECTRON MICROSCOPY; EXTRACTION; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; LIPID METABOLISM; LIPID STORAGE; LIPOPHILICITY; LYSOSOME; MITOCHONDRION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; THIN LAYER CHROMATOGRAPHY;

TRIXIS;

EID: 0142011505     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(03)00121-5     Document Type: Article

References (53)

1. 1H NMR-visible lipids are induced by phosphonium salts and 5-fluorouracil in human breast cancer cells. Magn. Reson. Med. 45:2001;1001-1010.
2. Delikatny E.J., Roman S.K., Hancock R., Jeitner T.M., Lander C.M., Rideout D.C., Mountford C.E. Tetraphenylphosphonium chloride induced MR-visible lipid accumulation in a malignant human breast cell line. Int. J. Cancer. 67:1996;72-79.
3. Roman S.K., Jeitner T.M., Hancock R., Cooper W.A., Rideout D.C., Delikatny E.J. Induction of magnetic resonance-visible lipid in a transformed human breast cell line by tetraphenylphosphonium chloride. Int. J. Cancer. 73:1997;570-579.
4. Delikatny E.J., Cooper W.A., Brammah S., Sathasivam N., Rideout D.C. Nuclear magnetic resonance-visible lipid accumulations induced by cationic lipophilic chemotherapeutic agents are accompanied by increased lipid droplet formation and damaged mitochondria. Cancer Res. 62:2002;1394-1400.
5. Blankenberg F.G., Katsikis P.D., Storrs R.W., Beaulieu C., Spielman D., Chen J.Y., Naumovski L., Tait J.F. Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. Blood. 89:1997;3778-3786.
6. 1H-MRS lipid signal modulation and morphological and ultrastructural changes related to tumor cell proliferation. Magn. Reson. Med. 42:1999;248-257.
7. 1H NMR visible lipids. Proc. Soc. Magn. Reson. Med. 3:1995;148.
8. Pilatus U., Davis D., Wehrle J., van Zijl P.C.M., Glickson J. Diffusion-weighted NMR spectroscopy of perfused MCF-7 cells: uptake of phenyl acetate. Proc. Soc. Magn. Res. Med. 2:1994;76.
9. 1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis. Nat. Med. 5:1999;1323-1327.
10. Ross B.D., Chenevert T.L., Kim B., Ben-Yoseph O. Magnetic resonance imaging and spectroscopy: application to experimental neuro-oncology. Q. Magn. Reson. Biol. Med. 1:1994;89-106.
11. 1H MR-visible lipid in human glioma cells is independent of the cell cycle. Int. J. Oncol. 11:1997;543-550.
12. 1H NMR spectra of a myeloma cell line correlates with the induced formation of cytoplasmic lipid droplets. Magn. Reson. Med. 29:1993;546-550.
13. 1H NMR-visible triacylglycerol in human neutrophils: high fatty acid environments result in preferential sequestration of palmitic acid into plasma membrane triacylglycerol. Eur. J. Biochem. 267:2000;68-78.
14. Delikatny E.J., Lander C.M., Jeitner T.M., Hancock R., Mountford C.E. Modulation of MR-visible mobile lipid levels by cell culture conditions and correlations with chemotactic response. Int. J. Cancer. 65:1996;238-245.
15. Barba I., Cabañas M.E., Arús C. The relationship between nuclear magnetic resonance-visible lipids, lipid droplets, and cell proliferation in cultured C6 cells. Cancer Res. 59:1999;1861-1868.
16. Barba I., Mann P., Cabañas M.E., Arús C., Gasparovic C. Mobile lipid production after confluence and pH stress in perfused C6 cells. NMR Biomed. 14:2001;33-40.
17. 1H NMR-visible mobile lipid domains correlate with cytoplasmic lipid bodies in apoptotic T-lymphoblastoid cells. Biochim. Biophys. Acta. 1530:2001;47-66.
18. 1H NMR spectroscopy. Cell Death Differ. 8:2001;219-224.
19. Al-Saffar N.M., Titley J.C., Robertson D., Clarke P.A., Jackson L.E., Leach M.O., Ronen S.M. Apoptosis is associated with triacylglycerol accumulation in Jurkat T-cells. Br. J. Cancer. 86:2002;963-970.
20. 1H MR spectroscopy. NMR Biomed. 7:1994;172-180.
21. 1H MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue. NMR Biomed. 7:1994;149-155.
22. Freitas I., Pontiggia P., Barni S., Bertone V., Parente M., Novarina A., Roveta G., Gerzeli G., Stoward P. Histochemical probes for the detection of hypoxic tumour cells. Anticancer Res. 10:1990;613-622.
23. Freitas I., Barni S., Parente M., Bertone V., Roverta G., Novarina A., Stoward P.J. Mitochondrial degeneration in Yoshida hepatoma. An ultrastructural study. Med. Biol. Environ. 17:1989;115-120.
24. Robbins S.L., Cotran R.S., Kumar V. Pathologic Basis of Disease. 3rd ed. 1984;Saunders, Philadelphia.
25. Mountford C.E., Wright L.C. Organisation of lipids in the plasma membranes of malignant and stimulated cells: a new model. TIBS. 13:1988;172-177.
26. le Moyec L., Millot G., Tatoud R., Calvo G., Eugène M. Lipid signals detected by NMR proton spectroscopy of whole cells are not correlated to lipid droplets evidenced by the Nile red staining. Cell. Mol. Biol. 43:1997;703-709.
27. 1H-NMR- detectable mobile lipid domains in NIH-3T3 fibroblasts. Biochim. Biophys. Acta. 1438:1999;329-348.
28. Rideout D., Calogeropoulou T., Jaworski J.S., Dagnino R., McCarthy M.R. Phosphonium salts exhibiting selective anticarcinoma activity in vitro. Anti-Cancer Drug Des. 4:1989;265-280.
29. Rideout D., Bustamante A., Patel J. Mechanism of inhibition of FaDu hypopharyngeal carcinoma cell growth by tetraphenylphosphonium chloride. Int. J. Cancer. 57:1994;247-253.
30. Rideout D., Calogeropoulou T., Jaworski J., McCarthy M. Synergism through direct covalent bonding between agents: a strategy for rational design of chemotherapeutic combinations. Biopolymers. 29:1990;247-262.
31. Lampidis T.J., Bernal S.D., Summerhayes I.C., Chen L.B. Selective toxicity of rhodamine 123 in carcinoma cells in vitro. Cancer Res. 43:1983;716-720.
32. Davis S., Weiss M.J., Wong J.R., Lampidis T.J., Chen L.B. Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine-123 by human breast adenocarcinoma-derived MCF-7 cells. J. Biol. Chem. 260:1985;13844-13850.
33. Modica-Napolitano J.S., Koya K., Weisberg E., Brunelli B.T., Li Y., Chen L.B. Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077. Cancer Res. 56:1996;544-550.
34. Naressi A., Couturier C., Devos J.M., Janssen M., Mangeat C., de Beer R., Graveron-Demilly D. Java-based graphical user interface for the MRUI quantitation package. Magma. 12:2001;141-152.
35. Vanhamme L., van den Boogaart A., Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J. Magn. Reson. 129:1997;35-43.
36. Nakamura K., Handa S. Coomassie brilliant blue staining of lipids on thin layer plates. Anal. Biochem. 142:1984;406-410.
37. Wills E.J., Carr S., Philips J. Electron microscopy in the diagnosis of percutaneous fine needle aspiration specimens. Ultrastruct. Pathol. 11:1987;361-387.
38. Mangold H.K. Aliphatic lipids. Stahl E. Thin-Layer Chromatography, A Laboratory Handbook. 1969;363-420 Springer-Verlag, New York.
39. Evenson D.P., Lee J., Darzynkiewicz Z., Melamed M.R. Rhodamine 123 alters the mitochondrial ultrastructure of cultured L1210 cells. J. Histochem. Cytochem. 33:1985;353-359.
40. 1H-NMR-detectable mobile lipid in stimulated lymphocytes: relationship to cellular activation, the cell cycle, and phosphatidyl-specific phospholipase C. Biochem. Biophys. Res. Commun. 239:1997;868-874.
41. Lehner R., Kuksis A. Biosynthesis of triacylglycerols. Prog. Lipid Res. 35:1996;169-201.
42. Brindley D.N. Metabolism of triacylglycerols. Vance D.E., Vance J. Biochemistry of Lipids, Lipoproteins and Membranes. vol. 20:1991;171-203 Elsevier, Amsterdam.
43. Cantafora A., Blotta I. Neutral lipids production, transport, utilization. Anticancer Res. 16:1996;1441-1449.
44. Hostetler K.Y., Matsuzawa Y. Studies on the mechanism of drug-induced lipidosis. Cationic amphiphilic drug inhibition of lysosomal phospholipases A and C. Biochem. Pharmacol. 30:1981;1121-1126.
45. Kubo M., Hostetler K.Y. Mechanism of cationic amphiphilic drug inhibition of purified lysosomal phospholipase A1. Biochemistry. 24:1985;6515-6520.
46. Leli U., Hauser G. Mechanism of modification of rat brain lysophospholipase A activity by cationic amphiphilic drugs. Biochim. Biophys. Acta. 918:1987;126-135.
47. Hopewell R., Martin-Sanz P., Martin A., Saxton J., Brindley D.N. Regulation of the translocation of phosphatidate phosphohydrolase between the cytosol and the endoplasmic reticulum of rat liver. Effects of unsaturated fatty acids, spermine, nucleotides, albumin and chlorpromazine. Biochem. J. 232:1985;485-491.
48. Zborowski J., Brindley D.N. The metabolism of CDP-diacylglycerol and phosphatidylinositol in the microsomal fraction of rat liver. Effects of chlorpromazine, magnesium and manganese. Biochim. Biophys. Acta. 751:1983;81-89.
49. Jamal Z., Martin A., Gomez-Munoz A., Brindley D.N. Plasma membrane fractions from rat liver contain a phosphatidate phosphohydrolase distinct from that in the endoplasmic reticulum and cytosol. J. Biol. Chem. 266:1991;2988-2996.
50. Martin A., Hopewell R., Martin-Sanz P., Morgan J.E., Brindley D.N. Relationship between the displacement of phosphatidate phosphohydrolase from the membrane-associated compartment by chlorpromazine and the inhibition of the synthesis of triacylglycerol and phosphatidylcholine in rat hepatocytes. Biochim. Biophys. Acta. 876:1986;581-591.
51. Glaumann H., Ahlberg J. Comparison of different autophagic vacuoles with regard to ultrastructure, enzymatic composition, and degradation capacity-formation of crinosomes. Exp. Mol. Pathol. 47:1987;346-362.
52. Drenckhahn D., Kleine L., Lullmann-Rauch R. Lysosomal alterations in cultured macrophages exposed to anorexigenic and psychotropic drugs. Lab. Invest. 35:1976;116-123.
53. Ghadially F.N. Ultrastructural Pathology of the Cell and Matrix. 2nd ed. 1982;Butterworths, Sydney.